H. Lundbeck A/S Navne-Aktier B

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

26.44%

Market Cap

-

P/E Ratio

13.41

Dividend Yield

2.66 %

Earnings per Share

0.43 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE5.7 G0 Units
PRICE DETERMINATION TIME07/23/2026 / 07:38:00 AM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW5.75.7
PREV. DAY'S PRICE5.7 (07/22)
CHANGE DAY BEFORE
+0.00
0.00 %
52 WEEK HIGH / LOW6.305 (10/30)4.444 (08/04)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.310.430.430.620.63
DIVIDENDS PER SHARE
0.090.130.150.210.22
DIVIDEND YIELD IN %
2.14 %2.30 %2.66 %--
DIVIDEND GROWTH IN %
20.26 %35.58 %21.18 %--
PRICE - EARNINGS RATIO
14.1913.0313.419.229.01
PRICE - BOOK RATIO
1.471.641.72--
PRICE - SALES RATIO
1.631.861.76--
PRICE - CASH FLOW RATIO
7.9612.048.74--
Further Key Figures

Master Data

WKN
A3DMBV
ISIN
DK0061804770
SYMBOL
LDBA
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
H. LUNDBECK A/S SER.B DK1
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
3.35 %
2.52 %
-0.70 %
-3.80 %
26.44 %
30.79 %
-
0.26 %
HIGH5.745.926.126.186.316.57-6.26
LOW5.515.495.334.884.443.68-4.88

Dividende

pro Aktie

Company profile

H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. It operates through the following geographical segments: Europe, United States, and International Operations. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.